See more : GBLT Corp. (GBLTF) Income Statement Analysis – Financial Results
Complete financial analysis of PT Mitra Keluarga Karyasehat Tbk (MIKA.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Mitra Keluarga Karyasehat Tbk, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Keda Industrial Group Co., Ltd. (600499.SS) Income Statement Analysis – Financial Results
- Lefteris Acquisition Corp. (LFTRU) Income Statement Analysis – Financial Results
- Prime Strategy Co., Ltd. (5250.T) Income Statement Analysis – Financial Results
- Hang Zhou Iron & Steel Co.,Ltd. (600126.SS) Income Statement Analysis – Financial Results
- SSY Group Limited (LJUIF) Income Statement Analysis – Financial Results
PT Mitra Keluarga Karyasehat Tbk (MIKA.JK)
About PT Mitra Keluarga Karyasehat Tbk
PT Mitra Keluarga Karyasehat Tbk, together with its subsidiaries, owns and operates hospitals in Indonesia. The company provides healthcare services; and operates a pharmacy. Its hospital network comprises of 17 Mitra Keluarga hospitals and 9 Kasih Group hospitals located in Jakarta, Bekasi, Cikarang, Depok, Cibubur, Tangerang, Sukabumi, Karawang, Cirebon, Surabaya, Cibinong, Subang, and Tegal. The company was founded in 1989 and is headquartered in Jakarta, Indonesia. PT Mitra Keluarga Karyasehat Tbk is a subsidiary of PT Griyainsani Cakrasadaya.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4,264.28B | 4,048.93B | 4,352.87B | 3,419.34B | 3,205.02B | 2,713.09B | 2,495.71B | 2,435.47B | 2,140.70B | 1,945.51B | 1,742.09B | 1,475.39B |
Cost of Revenue | 2,296.23B | 1,971.91B | 2,091.51B | 1,727.31B | 1,670.65B | 1,428.79B | 1,310.19B | 1,279.67B | 1,168.40B | 1,080.92B | 1,004.79B | 881.03B |
Gross Profit | 1,968.05B | 2,077.02B | 2,261.36B | 1,692.04B | 1,534.37B | 1,284.30B | 1,185.52B | 1,155.80B | 972.31B | 864.59B | 737.30B | 594.36B |
Gross Profit Ratio | 46.15% | 51.30% | 51.95% | 49.48% | 47.87% | 47.34% | 47.50% | 47.46% | 45.42% | 44.44% | 42.32% | 40.29% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 355.65B | 314.26B | 251.56B | 219.97B | 211.70B | 180.92B | 173.61B | 159.20B | 148.39B | 130.10B | 108.34B | 0.00 |
Selling & Marketing | 39.00B | 21.45B | 22.08B | 18.92B | 20.29B | 13.98B | 9.76B | 9.44B | 6.33B | 4.28B | 4.20B | 0.00 |
SG&A | 783.59B | 335.71B | 273.64B | 238.89B | 231.99B | 194.90B | 183.37B | 168.64B | 154.71B | 134.38B | 112.54B | 230.79B |
Other Expenses | -30.84B | 434.12B | 349.68B | 401.45B | 400.86B | 11.35B | 13.09B | 8.94B | 10.49B | 7.11B | 8.35B | 0.00 |
Operating Expenses | 783.59B | 769.83B | 623.32B | 640.33B | 632.85B | 527.61B | 441.66B | 406.89B | 366.90B | 303.10B | 254.62B | 204.36B |
Cost & Expenses | 3,057.26B | 2,741.74B | 2,714.83B | 2,367.64B | 2,303.50B | 1,956.39B | 1,751.85B | 1,686.56B | 1,535.30B | 1,384.02B | 1,259.41B | 1,085.39B |
Interest Income | 72.07B | 58.38B | 63.53B | 67.18B | 75.29B | 84.73B | 130.61B | 162.73B | 145.34B | 94.72B | 63.36B | 0.00 |
Interest Expense | 15.50B | 12.88B | 12.22B | 11.48B | 13.59B | 2.82B | 1.06B | 12.14B | 10.49B | 792.08M | 2.19B | 0.00 |
Depreciation & Amortization | 276.30B | 233.32B | 194.56B | 180.25B | 160.84B | 134.52B | 113.46B | 101.49B | 40.95B | 34.91B | 31.04B | -374.28B |
EBITDA | 1,555.39B | 1,632.60B | 1,926.30B | 1,361.48B | 1,178.76B | 905.74B | 1,003.83B | 1,009.94B | 842.13B | 679.25B | 563.24B | 15.72B |
EBITDA Ratio | 36.47% | 37.08% | 41.85% | 35.90% | 33.64% | 33.38% | 37.16% | 39.35% | 36.62% | 34.91% | 32.71% | 1.07% |
Operating Income | 1,207.02B | 1,340.90B | 1,668.21B | 1,114.05B | 942.63B | 780.33B | 759.76B | 745.72B | 604.92B | 586.32B | 481.84B | 374.28B |
Operating Income Ratio | 28.31% | 33.12% | 38.32% | 32.58% | 29.41% | 28.76% | 30.44% | 30.62% | 28.26% | 30.14% | 27.66% | 25.37% |
Total Other Income/Expenses | 56.57B | 45.50B | 51.31B | 55.70B | 61.71B | 69.82B | 117.40B | 150.59B | 134.86B | 80.47B | 48.17B | 15.72B |
Income Before Tax | 1,263.59B | 1,386.40B | 1,719.52B | 1,169.75B | 1,004.33B | 850.15B | 877.15B | 896.31B | 739.78B | 666.80B | 530.01B | 390.00B |
Income Before Tax Ratio | 29.63% | 34.24% | 39.50% | 34.21% | 31.34% | 31.34% | 35.15% | 36.80% | 34.56% | 34.27% | 30.42% | 26.43% |
Income Tax Expense | 267.33B | 292.44B | 357.99B | 246.28B | 212.91B | 191.41B | 168.39B | 175.59B | 151.33B | 132.54B | 118.17B | 91.13B |
Net Income | 916.13B | 1,007.99B | 1,228.82B | 841.67B | 730.15B | 613.56B | 679.81B | 695.44B | 566.82B | 517.00B | 398.65B | 298.88B |
Net Income Ratio | 21.48% | 24.90% | 28.23% | 24.62% | 22.78% | 22.61% | 27.24% | 28.55% | 26.48% | 26.57% | 22.88% | 20.26% |
EPS | 65.08 | 71.61 | 86.47 | 59.10 | 51.14 | 42.48 | 47.00 | 48.00 | 39.00 | 38.00 | 28.80 | 21.62 |
EPS Diluted | 65.08 | 71.61 | 86.47 | 59.10 | 51.14 | 42.48 | 47.00 | 48.00 | 39.00 | 38.00 | 28.80 | 21.62 |
Weighted Avg Shares Out | 14.08B | 14.08B | 14.21B | 14.24B | 14.28B | 14.44B | 14.55B | 14.55B | 14.43B | 13.82B | 13.28B | 13.82B |
Weighted Avg Shares Out (Dil) | 14.08B | 14.08B | 14.21B | 14.24B | 14.28B | 14.44B | 14.55B | 14.55B | 14.43B | 13.82B | 13.28B | 13.82B |
Source: https://incomestatements.info
Category: Stock Reports